Artículos de revistas
Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins The Bridge Between Mouse And Humans?
Registro en:
Journal Of Parasitology Research. , v. 2011, n. , p. - , 2011.
20900023
10.1155/2011/965369
2-s2.0-79955366710
Autor
Rodrigues M.M.
Bargieri D.Y.
Soares I.S.
Costa F.T.M.
Braga C.J.
Ferreira L.C.S.
Institución
Resumen
In the past 25 years, the development of an effective malaria vaccine has become one of the biggest riddles in the biomedical sciences. Experimental data using animal infection models demonstrated that it is possible to induce protective immunity against different stages of malaria parasites. Nonetheless, the vast body of knowledge has generated disappointments when submitted to clinical conditions and presently a single antigen formulation has progressed to the point where it may be translated into a human vaccine. In parallel, new means to increase the protective effects of antigens in general have been pursued and depicted, such as the use of bacterial flagellins as carriers/adjuvants. Flagellins activate pathways in the innate immune system of both mice and humans. The recent report of the first Phase I clinical trial of a vaccine containing a Salmonella flagellin as carrier/adjuvant may fuel the use of these proteins in vaccine formulations. Herein, we review the studies on the use of recombinant flagellins as vaccine adjuvants with malarial antigens in the light of the current state of the art of malaria vaccine development. The available information indicates that bacterial flagellins should be seriously considered for malaria vaccine formulations to the development of effective human vaccines. Copyright © 2011 Daniel Y. Bargieri et al. 2011
Nussenzweig, R.S., Vanderberg, J., Most, H., Orton, C., Protective immunity produced by the injection of X-irradiated sporozoites of plasmodium berghei (1967) Nature, 216 (5111), pp. 160-162 Mueller, A.K., Labaied, M., Kappe, S., Matuschewski, K., Genetically modified Plasmodium parasites as a protective experimental malaria vaccine (2005) Nature, 13 (7022), pp. 164-167 Van Dijk, M.R., Douradinha, B., Franke-Fayard, B., Heussler, V., Van Dooren, M.W., Van Schaijk, B., Van Gemert, G.-J., Janse, C.J., Genetically attenuated P36p-deficient malarial sporozouites induce protective immunity and apoptosis of infected liver cells (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (34), pp. 12194-12199. , DOI 10.1073/pnas.0500925102 Vanbuskirk, K.M., O'Neill, M.T., De La Vega, P., Maier, A.G., Krzych, U., Williams, J., Dowler, M.G., Kappe, S.H.I., Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design (2009) Proceedings of the National Academy of Sciences of the United States of America, 106 (31), pp. 13004-13009 Ting, L.M., Gissot, M., Coppi, A., Sinnis, P., Kim, K., Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity (2008) Nature Medicine, 14 (9), pp. 954-958 Aly, A.S.I., Downie, M.J., Mamoun, C.B., Kappe, S.H.I., Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice (2010) Cellular Microbiology, 12 (7), pp. 930-938 Spaccapelo, R., Janse, C.J., Caterbi, S., Franke-Fayard, B., Bonilla, J.A., Syphard, L.M., Di Cristina, M., Crisanti, A., Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria (2010) American Journal of Pathology, 176 (1), pp. 205-217 Arun Kumar, K., Sano, G.-I., Boscardin, S., Nussenzweig, R.S., Nussenzweig, M.C., Zavala, F., Nussenzweig, V., The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites (2006) Nature, 444 (7121), pp. 937-940. , DOI 10.1038/nature05361, PII NATURE05361 Mauduit, M., Grner, A.C., Tewari, R., Depinay, N., Kayibanda, M., Chavatte, J.M., Franetich, J.F., Rnia, L., A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites (2009) PLoS ONE, 4 (11). , ARTICLE E7717 Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, R.S., Nussenzweig, V., Zavala, F., Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria (1989) Nature, 341 (6240), pp. 323-326. , DOI 10.1038/341323a0 Nardin, E.H., Herrington, D.A., Davis, J., Levine, M., Stuber, D., Takacs, B., Caspers, P., Nussenzweig, R.S., Conserved repetitive epitope recognized by CD4 + clones from a malaria-immunized volunteer (1989) Science, 246 (4937), pp. 1603-1606 Renia, L., Marussig, M.S., Grillot, D., Pied, S., Corradin, G., Mlltgen, F., Del Gludice, G., Mazier, D., In vitro activity of CD4 + and CD8 + T lymphocytes from mice immunized with a synthetic malaria peptide (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (18), pp. 7963-7967 Rodrigues, M.M., Cordey, A.S., Arreaza, G., Corradin, G., Romero, P., Maryanski, J.L., Nussenzweig, R.S., Zavala, F., CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria (1991) International Immunology, 3 (6), pp. 579-585 Malik, A., Egan, J.E., Houghten, R.A., Sadoff, J.C., Hoffman, S.L., Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (8), pp. 3300-3304 Tam, J.P., Clavijo, P., Lu, Y.-A., Nussenzweig, V., Nussenzweig, R., Zavala, F., Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria (1990) Journal of Experimental Medicine, 171 (1), pp. 299-306. , DOI 10.1084/jem.171.1.299 Nardin, E.H., Oliveira, G.A., Calvo-Calle, J.M., Nussenzweig, R.S., The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases (1995) Advances in Immunology, 60, pp. 105-149 Calvo-Calle, J.M., Oliveira, G.A., Watta, C.O., Soverow, J., Parra-Lopez, C., Nardin, E.H., A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge (2006) Infection and Immunity, 74 (12), pp. 6929-6939. , DOI 10.1128/IAI.01151-06 Bruna-Romero, O., Gonzalez-Aseguinolaza, G., Hafalla, J.C.R., Tsuji, M., Nussenzweig, R.S., Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (20), pp. 11491-11496. , DOI 10.1073/pnas.191380898 Reyes-Sandoval, A., Berthoud, T., Alder, N., Siani, L., Gilbert, S.C., Nicosia, A., Colloca, S., Hill, A.V.S., Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses (2010) Infection and Immunity, 78 (1), pp. 145-153 Ophorst, O.J.A.E., Radosevic, K., Havenga, M.J.E., Pau, M.G., Holterman, L., Berkhout, B., Goudsmit, J., Tsuji, M., Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice (2006) Infection and Immunity, 74 (1), pp. 313-320. , DOI 10.1128/IAI.74.1.313-320.2006 Shiratsuchi, T., Rai, U., Krause, A., Worgall, S., Tsuji, M., Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice (2010) Journal of Clinical Investigation, 120 (10), pp. 3688-3701 Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J.R., Esteban, M., Palese, P., Nussenzweig, R.S., Zavala, F., Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8 + T-cell-mediated protective immunity against malaria (1993) Proceedings of the National Academy of Sciences of the United States of America, 90 (11), pp. 5214-5218 Rodrigues, M., Li, S., Murata, K., Rodriguez, D., Rodriguez, J.R., Bacik, I., Bennink, J.R., Zavala, F., Influenza and vaccinia viruses expressing malaria CD8 + T and B cell epitopes: Comparison of their immunogenicity and capacity to induce protective immunity (1994) Journal of Immunology, 153 (10), pp. 4636-4648 Sedegah, M., Jones, T.R., Kaur, M., Hedstrom, R., Hobart, P., Tine, J.A., Hoffman, S.L., Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine (1998) Proceedings of the National Academy of Sciences of the United States of America, 95 (13), pp. 7648-7653. , DOI 10.1073/pnas.95.13.7648 Schneider, J., Gilbert, S.C., Blanchard, T.J., Hanke, T., Robson, K.J., Hannan, C.M., Becker, M., Hill, A.V.S., Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara (1998) Nature Medicine, 4 (4), pp. 397-402. , DOI 10.1038/nm0498-397 Webster, D.P., Dunachie, S., Vuola, J.M., Berthoud, T., Keating, S., Laidlaw, S.M., McConkey, S.J., Hill, A.V.S., Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (13), pp. 4836-4841. , DOI 10.1073/pnas.0406381102 Dunachie, S.J., Walther, M., Epstein, J.E., Keating, S., Berthoud, T., Andrews, L., Andersen, R.F., Hill, A.V.S., A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge (2006) Infection and Immunity, 74 (10), pp. 5933-5942. , DOI 10.1128/IAI.00590-06 Bejon, P., Ogada, E., Mwangi, T., Milligan, P., Lang, T., Fegan, G., Gilbert, S.C., Hill, A.V.S., Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya (2007) PLoS ONE, 2 (8). , ARTICLE E707 Schmidt, N.W., Podyminogin, R.L., Butler, N.S., Badovinac, V.P., Tucker, B.J., Bahjat, K.S., Lauer, P., Harty, J.T., Memory CD8+ T cell responses exceeding a large but definable threshold provide long-term immunity to malaria (2008) Proceedings of the National Academy of Sciences of the United States of America, 105 (37), pp. 14017-14022 Rodrigues, M., Nussenzweig, R.S., Romero, P., Zavala, F., The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules (1992) Journal of Experimental Medicine, 175 (4), pp. 895-905 Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J., Leach, A., From the circumsporozoite protein to the RTS,S/AS candidate vaccine (2010) Human Vaccines, 6 (1), pp. 90-96 Kester, K.E., Cummings, J.F., Ofori-Anyinam, O., Ockenhouse, C.F., Krzych, U., Moris, P., Schwenk, R., Heppner, D.G., Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection (2009) Journal of Infectious Diseases, 200 (3), pp. 337-346 Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Von Seidlein, L., Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age (2008) New England Journal of Medicine, 359 (24), pp. 2521-2532 Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., MacHera, F., Membi, C., Omari, S., Tanner, M., Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants (2008) New England Journal of Medicine, 359 (24), pp. 2533-2544 Gamain, B., Smith, J.D., Viebig, N.K., Gysin, J., Scherf, A., Pregnancy-associated malaria: Parasite binding, natural immunity and vaccine development (2007) International Journal for Parasitology, 37 (3-4), pp. 273-283. , DOI 10.1016/j.ijpara.2006.11.011, PII S0020751906004036 Wipasa, J., Riley, E.M., The immunological challenges of malaria vaccine development (2007) Expert Opinion on Biological Therapy, 7 (12), pp. 1841-1852. , DOI 10.1517/14712598.7.12.1841 Genton, B., Reed, Z.H., Asexual blood-stage malaria vaccine development: Facing the challenges (2007) Current Opinion in Infectious Diseases, 20 (5), pp. 467-475. , DOI 10.1097/QCO.0b013e3282dd7a29, PII 0000143220071000000005 Hviid, L., The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development (2010) Human Vaccines, 6 (1), pp. 84-89 Dahlbck, M., Nielsen, M.A., Salanti, A., Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains? (2010) Trends in Parasitology, 26 (5), pp. 230-235 Khunrae, P., Dahlbck, M., Nielsen, M.A., Andersen, G., Ditlev, S.B., Resende, M., Pinto, V.V., Salanti, A., Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies (2010) Journal of Molecular Biology, 397 (3), pp. 826-834 Reed, Z.H., Friede, M., Kieny, M.P., Malaria vaccine development: Progress and challenges (2006) Current Molecular Medicine, 6 (2), pp. 231-245 Yazdani, S.S., Mukherjee, P., Chauhan, V.S., Chitnis, C.E., Immune responses to asexual blood-stages of malaria parasites (2006) Current Molecular Medicine, 6 (2), pp. 187-203 Langhorne, J., Ndungu, F.M., Sponaas, A.-M., Marsh, K., Immunity to malaria: More questions than answers (2008) Nature Immunology, 9 (7), pp. 725-732. , DOI 10.1038/ni.f.205, PII NI.F.205 Kadekoppala, M., Holder, A.A., Merozoite surface proteins of the malaria parasite: The MSP1 complex and the MSP7 family (2010) International Journal for Parasitology, 40 (10), pp. 1155-1161 Remarque, E.J., Faber, B.W., Kocken, C.H.M., Thomas, A.W., Apical membrane antigen 1: A malaria vaccine candidate in review (2008) Trends in Parasitology, 24 (2), pp. 74-84 Chitnis, C.E., Sharma, A., Targeting the Plasmodium vivax Duffy-binding protein (2008) Trends in Parasitology, 24 (1), pp. 29-34 Brown, A., Higgins, M.K., Carbohydrate binding molecules in malaria pathology (2010) Current Opinion in Structural Biology, 20 (5), pp. 560-566 Babon, J.J., Morgan, W.D., Kelly, G., Eccleston, J.F., Feeney, J., Holder, A.A., Structural studies on Plasmodium vivax merozoite surface protein-1 (2007) Molecular and Biochemical Parasitology, 153 (1), pp. 31-40. , DOI 10.1016/j.molbiopara.2007.01.015, PII S0166685107000412 O'Donnell, R.A., Saul, A., Cowman, A.F., Crabb, B.S., Functional conservation of the malaria vaccine antigen MSP-1 19 across distantly related Plasmodium species (2000) Nature Medicine, 6 (1), pp. 91-95. , DOI 10.1038/71595 Sanders, P.R., Kats, L.M., Drew, D.R., O'Donnell, R.A., O'Neill, M., Maier, A.G., Coppel, R.L., Crabb, B.S., A set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion (2006) Infection and Immunity, 74 (7), pp. 4330-4338. , DOI 10.1128/IAI.00054-06 Combe, A., Giovannini, D., Carvalho, T.G., Spath, S., Boisson, B., Loussert, C., Thiberge, S., Mnard, R., Clonal conditional mutagenesis in malaria parasites (2009) Cell Host and Microbe, 5 (4), pp. 386-396 Daly, T.M., Long, C.A., A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice (1993) Infection and Immunity, 61 (6), pp. 2462-2467 Daly, T.M., Long, C.A., Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection (1996) Infection and Immunity, 64 (7), pp. 2602-2608 Singh, B., Cabrera-Mora, M., Jiang, J., Galinski, M., Moreno, A., Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate (2010) Vaccine, 28 (14), pp. 2580-2592 Perera, K.L.R.L., Handunnetti, S.M., Holm, I., Longacre, S., Mendis, K., Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for Human Plasmodium vivax Malaria (1998) Infection and Immunity, 66 (4), pp. 1500-1506 Lyon, J.A., Angov, E., Fay, M.P., Sullivan, J.S., Girourd, A.S., Robinson, S.J., Bergmann-Leitner, E.S., Barnwell, J.W., Protection induced by plasmodium falciparum MSP1 is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses (2008) PLoS ONE, 3 (7). , ARTICLE E2830 Ogutu, B.R., Apollo, O.J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Withers, M.R., Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya (2009) PLoS ONE, 4 (3). , ARTICLE E4708 Reed, Z.H., Kieny, M.P., Engers, H., Friede, M., Chang, S., Longacre, S., Malhotra, P., Long, C., Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits (2009) Vaccine, 27 (10), pp. 1651-1660 Ramos, H.C., Rumbo, M., Sirard, J.-C., Bacterial flagellins: Mediators of pathogenicity and host immune responses in mucosa (2004) Trends in Microbiology, 12 (11), pp. 509-517. , DOI 10.1016/j.tim.2004.09.002, PII S0966842X04002069 Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., Eng, J.K., Aderem, A., The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 (2001) Nature, 410 (6832), pp. 1099-1103. , DOI 10.1038/35074106 Smith, K.D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M.A., Rassoulian Barrett, S.L., Cookson, B.T., Aderem, A., Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility (2003) Nature Immunology, 4 (12), pp. 1247-1253. , DOI 10.1038/ni1011 Means, T.K., Hayashi, F., Smith, K.D., Aderem, A., Luster, A.D., The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells (2003) Journal of Immunology, 170 (10), pp. 5165-5175 Arimilli, S., Johnson, J.B., Clark, K.M., Graff, A.H., Alexander-Miller, M.A., Mizel, S.B., Parks, G.D., Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function (2008) Journal of Virology, 82 (22), pp. 10975-10985 Merlo, A., Calcaterra, C., Menard, S., Balsari, A., Cross-talk between Toll-like receptors 5 and 9 on activation of human immune responses (2007) Journal of Leukocyte Biology, 82 (3), pp. 509-518. , http://www.jleukbio.org/cgi/reprint/82/3/509, DOI 10.1189/jlb.0207100 Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., Pulendran, B., Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-Fos (2003) Journal of Immunology, 171 (10), pp. 4984-4989 Didierlaurent, A., Ferrero, I., Otten, L.A., Dubois, B., Reinhard, M., Carlsen, H., Blomhoff, R., Sirard, J.-C., Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response (2004) Journal of Immunology, 172 (11), pp. 6922-6930 Bates, J.T., Uematsu, S., Akira, S., Mizel, S.B., Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin (2009) Journal of Immunology, 182 (12), pp. 7539-7547 Miao, E.A., Alpuche-Aranda, C.M., Dors, M., Clark, A.E., Bader, M.W., Miller, S.I., Aderem, A., Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf (2006) Nature Immunology, 7 (6), pp. 569-575. , DOI 10.1038/ni1344, PII N1344 Lightfield, K.L., Persson, J., Brubaker, S.W., Witte, C.E., Von Moltke, J., Dunipace, E.A., Henry, T., Vance, R.E., Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin (2008) Nature Immunology, 9 (10), pp. 1171-1178 Zamboni, D.S., Kobayashi, K.S., Kohlsdorf, T., Ogura, Y., Long, E.M., Vance, R.E., Kuida, K., Roy, C.R., The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection (2006) Nature Immunology, 7 (3), pp. 318-325 Vinzing, M., Eitel, J., Lippmann, J., Hocke, A.C., Zahlten, J., Slevogt, H., N'Guessan, P.D., Opitz, B., NAIP and Ipaf control Legionella pneumophila replication in human cells (2008) Journal of Immunology, 180 (10), pp. 6808-6815 Buzzo, C.L., Campopiano, J.C., Massis, L.M., Lage, S.L., Cassado, A.A., Leme-Souza, R., Cunha, L.D., Bortoluci, K.R., A novel pathway for inducible nitric-oxide synthase activation through inflammasomes (2010) Journal of Biological Chemistry, 285 (42), pp. 32087-32095 Bortoluci, K.R., Medzhitov, R., Control of infection by pyroptosis and autophagy: Role of TLR and NLR (2010) Cellular and Molecular Life Sciences, 67 (10), pp. 1643-1651 Newton, S.M.C., Jacob, C.O., Stocker, B.A.D., Immune response to cholera toxin epitope inserted in Salmonella flagellin (1989) Science, 244 (4900), pp. 70-72 McEwen, J., Levi, R., Horwitz, R.J., Arnon, R., Synthetic recombinant vaccine expressing influenza haemagluttinin epitope in Salmonella flagellin leads to partial protection in mice (1992) Vaccine, 10 (6), pp. 405-411 Luna, M.G., Martins, M.M., Newton, S.M.C., Costa, S.O.P., Almeida, D.F., Ferreira, L.C.S., Cloning and expression of colonization factor antigen I (CFA/I) epitopes of enterotogenic Escherichia coli (ETEC) in Salmonella flagellin (1997) Research in Microbiology, 148 (3), pp. 217-228. , DOI 10.1016/S0923-2508(97)85242-4 Mizel, S.B., Bates, J.T., Flagellin as an adjuvant: Cellular mechanisms and potential (2010) Journal of Immunology, 185 (10), pp. 5677-5682 Huleatt, J.W., Nakaar, V., Desai, P., Huang, Y., Hewitt, D., Jacobs, A., Tang, J., Powell, T.J., Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin (2008) Vaccine, 26 (2), pp. 201-214. , DOI 10.1016/j.vaccine.2007.10.062, PII S0264410X0701256X Song, L., Nakaar, V., Kavita, U., Price, A., Huleatt, J., Tang, J., Jacobs, A., Tussey, L., Efficacious recombinant influenza vaccines produced by high yield bacterial expression: A solution to global pandemic and seasonal needs (2008) PLoS ONE, 3 Treanor, J.J., Taylor, D.N., Tussey, L., Hay, C., Nolan, C., Fitzgerald, T., Liu, G., Shaw, A., Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults (2010) Vaccine, 28 (52), pp. 8268-8274 Barbedo, M.B., Ricci, R., Jimenez, M.C.S., Cunha, M.G., Yazdani, S.S., Chitnis, C.E., Rodrigues, M.M., Soares, I.S., Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax (2007) Memorias do Instituto Oswaldo Cruz, 102 (3), pp. 335-339. , http://memorias.ioc.fiocruz.br/5787.pdf Soares, I.S., Barnwell, J.W., Ferreira, M.U., Da Cunha, M.G., Laurino, J.P., Castilho, B.A., Rodrigues, M.M., A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies (1999) Molecular Medicine, 5 (7), pp. 459-470 Rodrigues, M.H.C., Cunha, M.G., Machado, R.L.D., Ferreira Jr., O.C., Rodrigues, M.M., Soares, I.S., Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1 (2003) Malaria Journal, 2, pp. 1-7. , http://www.malariajournal.com/content/2/1/39, DOI 10.1186/1475-2875-2-1, 1 Dutta, S., Kaushal, D.C., Ware, L.A., Puri, S.K., Kaushal, N.A., Narula, A., Upadhyaya, D.S., Lanar, D.E., Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys (2005) Infection and Immunity, 73 (9), pp. 5936-5944. , DOI 10.1128/IAI.73.9.5936-5944.2005 Bargieri, D.Y., Rosa, D.S., Braga, C.J.M., Carvalho, B.O., Costa, F.T.M., Espndola, N.M., Vaz, A.J., Rodrigues, M.M., New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin (2008) Vaccine, 26 (48), pp. 6132-6142 Bargieri, D.Y., Leite, J.A., Lopes, S.C.P., Sbrogio-Almeida, M.E., Braga, C.J.M., Ferreira, L.C.S., Soares, I.S., Rodrigues, M.M., Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium (2010) Vaccine, 28 (16), pp. 2818-2826 Braga, C.J.M., Massis, L.M., Sbrogio-Almeida, M.E., Alencar, B.C.G., Bargieri, D.Y., Boscardin, S.B., Rodrigues, M.M., Ferreira, L.C.S., CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein (2010) Vaccine, 28 (5), pp. 1373-1382 Pino, O., Martin, M., Michalek, S.M., Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica serovar typhimurium to potentiate mucosal and systemic responses (2005) Infection and Immunity, 73 (10), pp. 6763-6770. , DOI 10.1128/IAI.73.10.6763-6770.2005 Datta, S.K., Redecke, V., Prilliman, K.R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Raz, E., A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells (2003) Journal of Immunology, 170 (8), pp. 4102-4110 Vicente-Suarez, I., Brayer, J., Villagra, A., Cheng, F., Sotomayor, E.M., TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses (2009) Immunology Letters, 125 (2), pp. 114-118 Sanders, C.J., Franchi, L., Yarovinsky, F., Uematsu, S., Akira, S., Nez, G., Gewirtz, A.T., Induction of adaptive immunity by flagellin does not require robust activation of innate immunity (2009) European Journal of Immunology, 39 (2), pp. 359-371 Vijay-Kumar, M., Carvalho, F.A., Aitken, J.D., Fifadara, N.H., Gewirtz, A.T., TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin (2010) European Journal of Immunology, 40 (12), pp. 3528-3534